Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Targeting bioenergetics is key to counteracting the drug-tolerant state of biofilm-grown bacteria

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  4. Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Neutralizing Antibodies Against Hepatitis C Virus and Their Role in Vaccine Immunity

    Publikation: Bidrag til tidsskriftLederpeer review

Vis graf over relationer

Hepatitis C virus (HCV) chronically infects 70 million people worldwide with an estimated annual disease-related mortality of 400,000. A vaccine could prevent spread of this pervasive human pathogen, but has proven difficult to develop, partly due to neutralizing antibody evasion mechanisms that are inherent features of the virus envelope glycoproteins, E1 and E2. A central actor is the E2 motif, hypervariable region 1 (HVR1), which protects several non-overlapping neutralization epitopes through an incompletely understood mechanism. Here, we show that introducing different HVR1-isolate sequences into cell-culture infectious JFH1-based H77 (genotype 1a) and J4 (genotype 1b) Core-NS2 recombinants can lead to severe viral attenuation. Culture adaptation of attenuated HVR1-swapped recombinants permitted us to identify E1/E2 substitutions at conserved positions both within and outside HVR1 that increased the infectivity of attenuated HVR1-swapped recombinants but were not adaptive for original recombinants. H77 recombinants with HVR1 from multiple other isolates consistently acquired substitutions at position 348 in E1 and position 385 in HVR1 of E2. Interestingly, HVR1-swapped J4 recombinants primarily acquired other substitutions: F291I (E1), F438V (E2), F447L/V/I (E2) and V710L (E2), indicating a different adaptation pathway. For H77 recombinants, the adaptive E1/E2 substitutions increased sensitivity to the neutralizing monoclonal antibodies AR3A and AR4A, whereas for J4 recombinants, they increased sensitivity to AR3A, while having no effect on sensitivity to AR4A. To evaluate effects of the substitutions on AR3A and AR4A binding, we performed ELISAs on extracted E1/E2 protein and performed immunoprecipitation of relevant viruses. However, extracted E1/E2 protein and immunoprecipitation of HCV particles only reproduced the neutralization phenotypes of the J4 recombinants. Finally, we found that the HVR1-swap E1/E2 substitutions decrease virus entry dependency on co-receptor SR-BI. Our study identifies E1/E2 positions that could be critical for intra-complex HVR1 interactions while emphasizing the need for developing novel tools for molecular studies of E1/E2 interactions.

OriginalsprogEngelsk
Artikelnummere1009720
TidsskriftP L o S Pathogens
Vol/bind17
Udgave nummer7
Sider (fra-til)1-29
Antal sider29
ISSN1553-7366
DOI
StatusUdgivet - jul. 2021

ID: 66871583